These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 22950794)

  • 1. Role of regulatory micro RNAs in type 2 diabetes mellitus-related inflammation.
    Hamar P
    Nucleic Acid Ther; 2012 Oct; 22(5):289-94. PubMed ID: 22950794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease.
    Estep M; Armistead D; Hossain N; Elarainy H; Goodman Z; Baranova A; Chandhoke V; Younossi ZM
    Aliment Pharmacol Ther; 2010 Aug; 32(3):487-97. PubMed ID: 20497147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased tenascin C and Toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity.
    Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Rotellar F; Valentí V; Silva C; Gil MJ; Salvador J; Frühbeck G
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1880-9. PubMed ID: 22851489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Connection between MicroRNAs from Visceral Adipose Tissue and Non-Alcoholic Fatty Liver Disease.
    Zubáňová V; Červinková Z; Kučera O; Palička V
    Acta Medica (Hradec Kralove); 2021; 64(1):1-7. PubMed ID: 33855952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.
    Sharma H; Estep M; Birerdinc A; Afendy A; Moazzez A; Elariny H; Goodman Z; Chandhoke V; Baranova A; Younossi ZM
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1410-5. PubMed ID: 23663110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus.
    He Y; Ding Y; Liang B; Lin J; Kim TK; Yu H; Hang H; Wang K
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance.
    Wang XA; Zhang R; Zhang S; Deng S; Jiang D; Zhong J; Yang L; Wang T; Hong S; Guo S; She ZG; Zhang XD; Li H
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E485-95. PubMed ID: 23695216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
    Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
    Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammation.
    Wensveen FM; Valentić S; Šestan M; Turk Wensveen T; Polić B
    Eur J Immunol; 2015 Sep; 45(9):2446-56. PubMed ID: 26220361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protein profile of visceral adipose tissues linked to early pathogenesis of type 2 diabetes mellitus.
    Kim SJ; Chae S; Kim H; Mun DG; Back S; Choi HY; Park KS; Hwang D; Choi SH; Lee SW
    Mol Cell Proteomics; 2014 Mar; 13(3):811-22. PubMed ID: 24403596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does microRNA Perturbation Control the Mechanisms Linking Obesity and Diabetes? Implications for Cardiovascular Risk.
    La Sala L; Crestani M; Garavelli S; de Candia P; Pontiroli AE
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
    World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral fat and metabolic inflammation: the portal theory revisited.
    Item F; Konrad D
    Obes Rev; 2012 Dec; 13 Suppl 2():30-9. PubMed ID: 23107257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research Status of Differentially Expressed Noncoding RNAs in Type 2 Diabetes Patients.
    Shi R; Chen Y; Liao Y; Li R; Lin C; Xiu L; Yu H; Ding Y
    Biomed Res Int; 2020; 2020():3816056. PubMed ID: 33274206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
    Kaucsár T; Rácz Z; Hamar P
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicle-shuttled miRNAs: a critical appraisal of their potential as nano-diagnostics and nano-therapeutics in type 2 diabetes mellitus and its cardiovascular complications.
    Prattichizzo F; Matacchione G; Giuliani A; Sabbatinelli J; Olivieri F; de Candia P; De Nigris V; Ceriello A
    Theranostics; 2021; 11(3):1031-1045. PubMed ID: 33391519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).
    Ortiz-Lopez C; Lomonaco R; Orsak B; Finch J; Chang Z; Kochunov VG; Hardies J; Cusi K
    Diabetes Care; 2012 Apr; 35(4):873-8. PubMed ID: 22374640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Soluble ACE2 and Upstream microRNA Expressions in Serum of Type 2 Diabetes Mellitus Patients.
    Elemam NM; Hasswan H; Aljaibeji H; Sulaiman N
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes mellitus-related genetic polymorphisms in microRNAs and microRNA target sites.
    Gong W; Xiao D; Ming G; Yin J; Zhou H; Liu Z
    J Diabetes; 2014 Jul; 6(4):279-89. PubMed ID: 24606011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors.
    Reijrink M; de Boer SA; Spoor DS; Lefrandt JD; Lambers Heerspink HJ; Boellaard R; Greuter MJ; Borra RJH; Hillebrands JL; Slart RHJA; Mulder DJ
    Atherosclerosis; 2019 Nov; 290():87-93. PubMed ID: 31604171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.